Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: August 22, 2017
What is the patent landscape for Ranitidine Hydrochloride, and what generic Ranitidine Hydrochloride alternatives are available?
Ranitidine Hydrochloride is a drug marketed by Ranbaxy, Wockhardt, Apotex Inc, Bio Pharm Inc, Pharm Assoc, Dr Reddys Labs Inc, Amneal Pharms, Strides Pharma, Watson Labs, Sandoz, Aurobindo Pharma Ltd, Mylan, Actavis Mid Atlantic, Amneal Pharms Ny, Watson Labs Inc, Perrigo R And D, Sun Pharm Inds Ltd, Zydus Pharms Usa Inc, Dr Reddys Labs Ltd, Glenmark Pharms Inc, Tolmar, Teva, West-ward Pharms Int, Boehringer Ingelheim, Bedford, Ivax Sub Teva Pharms, Mylan Labs Ltd, Taro, Hi Tech Pharma, Apotex, Par Pharm, Breckenridge Pharm, Silarx, Vintage Pharms, Nostrum Labs Inc, Contract Pharmacal, and Perrigo. and is included in sixty-one NDAs.| Patents: | 0 |
| Applicants: | 37 |
| NDAs: | 61 |
| Suppliers / Packagers: see list | 133 |
| Bulk Api Vendors: see list | 83 |
| Clinical Trials: see list | 2,342 |
| Patent Applications: see list | 3 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | RANITIDINE HYDROCHLORIDE at DailyMed |
| Drug Class | Histamine-2 Receptor Antagonist |
| Mechanism of Action | Histamine H2 Receptor Antagonists |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breckenridge Pharm | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | SYRUP;ORAL | 078684-001 | Aug 27, 2009 | AA | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Mylan | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | TABLET;ORAL | 074552-002 | Jul 30, 1998 | DISCN | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
Sun Pharm Inds Ltd | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | TABLET;ORAL | 075439-001 | Apr 19, 2000 | DISCN | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
West-ward Pharms Int | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | INJECTABLE;INJECTION | 077458-001 | Feb 16, 2006 | AP | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Apotex Inc | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | TABLET;ORAL | 075167-001 | May 4, 2000 | OTC | No | No | ► Subscribe | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,373 others who get our Drug Patent Expiration Alerts:
